111![NewsBytes January 13th, 2015 The Chronicle Herald Glen Canning defends sharing explicit photo of MSVU prof International group supports call for inquiry into missing, killed native women Eskasoni woman arrested after ret NewsBytes January 13th, 2015 The Chronicle Herald Glen Canning defends sharing explicit photo of MSVU prof International group supports call for inquiry into missing, killed native women Eskasoni woman arrested after ret](https://www.pdfsearch.io/img/02ce676bb50b9d38bda5879a0876afea.jpg) | Add to Reading ListSource URL: women.gov.ns.caLanguage: English - Date: 2015-01-13 14:37:29
|
---|
112![Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio](https://www.pdfsearch.io/img/c8a45f5417405743fc503f2250a482d8.jpg) | Add to Reading ListSource URL: www.pmda.go.jpLanguage: English - Date: 2015-01-09 03:35:30
|
---|
113![Volume[removed]Editor: Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Contents Rasagiline - B Cadario Volume[removed]Editor: Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Contents Rasagiline - B Cadario](https://www.pdfsearch.io/img/d487c9cd6160af73d26ad1c77e01c808.jpg) | Add to Reading ListSource URL: dpic.orgLanguage: English - Date: 2014-11-10 15:46:27
|
---|
114![What’s “hot” about thermogenic agents What’s “hot” about thermogenic agents](https://www.pdfsearch.io/img/91c62075636a80bf1549c2f1fb0b00c0.jpg) | Add to Reading ListSource URL: dpic.orgLanguage: English - Date: 2014-11-10 15:46:31
|
---|
115![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral](https://www.pdfsearch.io/img/c8c56af1e673221ed3879409c760aa9b.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-07-25 12:30:45
|
---|
116![FDA Tentative Approval[removed]Efavirenz Capsules 50 mg, 100 mg, and 200 mg Aurobindo Pharma, Ltd. 1 FDA Tentative Approval[removed]Efavirenz Capsules 50 mg, 100 mg, and 200 mg Aurobindo Pharma, Ltd. 1](https://www.pdfsearch.io/img/eb0af2414795477372798fe3df953bd2.jpg) | Add to Reading ListSource URL: apps.who.intLanguage: English - Date: 2009-11-10 08:30:56
|
---|
117![Abstract # 1048 Phase I study of HM61713, a novel epidermal growth factor receptor (EGFR) mutant selective inhibitor, in non-small cell lung cancer (NSCLC) patients having an activating EGFR mutation but failed to prior Abstract # 1048 Phase I study of HM61713, a novel epidermal growth factor receptor (EGFR) mutant selective inhibitor, in non-small cell lung cancer (NSCLC) patients having an activating EGFR mutation but failed to prior](https://www.pdfsearch.io/img/8171bbcf3f681d22e6940ba879919063.jpg) | Add to Reading ListSource URL: www.hanmipharm.comLanguage: English - Date: 2014-03-27 02:03:41
|
---|
118![Astellas Submits Supplemental New Drug Application to FDA for Tarceva® as a First-Line Therapy in Genetically Distinct Form of Non-Small Cell Lung Cancer NORTHBROOK, Ill., Nov. 20, 2012 – Astellas Pharma US, Inc. (“ Astellas Submits Supplemental New Drug Application to FDA for Tarceva® as a First-Line Therapy in Genetically Distinct Form of Non-Small Cell Lung Cancer NORTHBROOK, Ill., Nov. 20, 2012 – Astellas Pharma US, Inc. (“](https://www.pdfsearch.io/img/35f7d7a7358d8a6502eef1cd44f30f5f.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2012-11-19 03:35:22
|
---|
119![6th Invitation to manufacturers of reproductive health products to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Team - Medicines (October 2014) 6th Invitation to manufacturers of reproductive health products to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Team - Medicines (October 2014)](https://www.pdfsearch.io/img/5d90de5645bde43fb060d07e22999fdf.jpg) | Add to Reading ListSource URL: apps.who.intLanguage: English - Date: 2014-10-01 03:40:22
|
---|
120![ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer](https://www.pdfsearch.io/img/94bbd66ffb561150bd80570009433671.jpg) | Add to Reading ListSource URL: dctd.cancer.govLanguage: English - Date: 2014-10-23 22:26:08
|
---|